{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:43:51Z","timestamp":1790959431613,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melanocytic Tumors of Uncertain Malignant Potential (MELTUMPs) remain among the most challenging entities in dermatopathology due to overlapping morphologic features and marked inter-observer variability. This comprehensive review critically assesses the diagnostic and potential prognostic significance of combining p16 and methylthioadenosine phosphorylase (MTAP) immunohistochemistry (IHC) as a practical surrogate for genomic alterations involving the 9p21 (CDKN2A\/MTAP) locus. We analyzed the molecular underpinnings of the CDKN2A\/MTAP axis and systematically reviewed existing literature to define an integrated IHC strategy for ambiguous melanocytic lesions. The combined use of p16, a sensitive marker of CDKN2A inactivation, and MTAP, a highly specific marker for homozygous 9p21 deletion, was assessed for its diagnostic complementarity and potential clinical utility. p16 IHC demonstrates high sensitivity but limited specificity due to heterogeneous staining in borderline lesions. In contrast, MTAP loss exhibits near-absolute specificity for CDKN2A\/MTAP co-deletion, albeit with lower sensitivity. Concordant loss of both markers strongly supports melanoma or high-risk melanocytoma, while MTAP retention may predict responsiveness to adjuvant interferon therapy. Combined p16\/MTAP IHC provides a synergistic, biologically grounded approach that refines diagnostic accuracy in MELTUMPs. This dual-marker algorithm promotes a shift from purely morphology-based evaluation toward a reproducible, molecularly informed classification, improving both diagnostic confidence and patient management.<\/jats:p>","DOI":"10.3390\/ijms27020971","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:27:58Z","timestamp":1768908478000},"page":"971","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Diagnostic and Prognostic Role of Combined p16 and MTAP Immunohistochemistry in Melanocytic Tumors of Uncertain Malignant Potential: A Comprehensive Review and Clinical Practice Analysis"],"prefix":"10.3390","volume":"27","author":[{"given":"Ludovica","family":"Pepe","sequence":"first","affiliation":[{"name":"Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-1761","authenticated-orcid":false,"given":"Vincenzo","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-7174","authenticated-orcid":false,"given":"Cristina","family":"Pizzimenti","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Papardo Hospital, 98158 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-6310","authenticated-orcid":false,"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacarmela","family":"Santarpia","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Department of Human Pathology \u201cG. Barresi\u201d, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Fazio","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Plastic Surgery Unit, University of Messina, Policlinico Hospital, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-5145","authenticated-orcid":false,"given":"Mario","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lentini","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ieni","sequence":"additional","affiliation":[{"name":"Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cpm.2021.06.012","article-title":"Plantar Melanoma","volume":"38","author":"An","year":"2021","journal-title":"Clin. Podiatr. Med. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CMR.0000000000000959","article-title":"Global Trends in Cutaneous Malignant Melanoma Incidence and Mortality","volume":"34","author":"Mignozzi","year":"2024","journal-title":"Melanoma Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fiorentino, V., Pizzimenti, C., Franchina, M., Pepe, L., Russotto, F., Tralongo, P., Micali, M.G., Militi, G.B., and Lentini, M. (2024). Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010676"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5858\/2010-0146-RA.1","article-title":"Nevus\/Melanocytoma\/Melanoma: An Emerging Paradigm for Classification of Melanocytic Neoplasms?","volume":"135","author":"Zembowicz","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.23736\/S0392-0488.17.05569-9","article-title":"MELTUMP: How to Manage These Lesions in the Clinical Routine","volume":"152","author":"Piccolo","year":"2017","journal-title":"Ital. J. Dermatol. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaad.2022.11.019","article-title":"Ambiguous Melanocytic Lesions: A Retrospective Cohort Study of Incidence and Outcome of Melanocytic Tumor of Uncertain Malignant Potential (MELTUMP) and Superficial Atypical Melanocytic Proliferation of Uncertain Significance (SAMPUS) in the Netherlands","volume":"88","author":"Doeleman","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/modpathol.2016.70","article-title":"A Diagnostic Algorithm for Atypical Spitzoid Tumors: Guidelines for Immunohistochemical and Molecular Assessment","volume":"29","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/modpathol.2017.23","article-title":"SF3B1 and BAP1 mutations in blue nevus-like melanoma","volume":"30","author":"Griewank","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/bjd.18947","article-title":"GNAQ and GNA11 mutant nonuveal melanoma: A subtype distinct from both cutaneous and uveal melanoma","volume":"183","author":"Livingstone","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/PAS.0000000000000902","article-title":"Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes","volume":"41","author":"Cohen","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jdv.18665","article-title":"Clinical Management of Melanocytic Tumours of Uncertain Malignant Potential (MelTUMPs), Including Melanocytomas: A Systematic Review and Meta-analysis","volume":"37","author":"Varey","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_12","first-page":"70","article-title":"Theory and Practical Application of Superficial Atypical Melanocytic Proliferations of Uncertain Significance (SAMPUS) and Melanocytic Tumours of Uncertain Malignant Potential (MELTUMP) Terminology: Experience with Second Opinion Consultation","volume":"104","author":"Pusiol","year":"2012","journal-title":"Pathologica"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/00313020412331283905","article-title":"The Approach to the Patient with a Difficult Melanocytic Lesion","volume":"36","author":"Elder","year":"2004","journal-title":"Pathology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/PAS.0000000000002297","article-title":"Prevalence of S-Methyl-5\u2032-Thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer","volume":"48","author":"Gorbokon","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_15","first-page":"100966","article-title":"A Systematic Literature Review of MTAP Deletions in Solid and Hematologic Cancers","volume":"44","author":"Clouser","year":"2025","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.7150\/ijbs.67149","article-title":"Downregulation of MTAP Promotes Tumor Growth and Metastasis by Regulating ODC Activity in Breast Cancer","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1440-1827.2010.02534.x","article-title":"9p21 Deletion in the Diagnosis of Malignant Mesothelioma, Using Fluorescence in Situ Hybridization Analysis","volume":"60","author":"Takeda","year":"2010","journal-title":"Pathol. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pathol.2023.01.005","article-title":"Evaluation of MTAP and P16 Immunohistochemical Deficiency as Surrogate Marker for CDKN2A\/B Homozygous Deletion in Gliomas","volume":"55","author":"Maragkou","year":"2023","journal-title":"Pathology"},{"key":"ref_19","first-page":"1","article-title":"9p21 Deletions in Primary Melanoma","volume":"3","author":"Naylor","year":"1997","journal-title":"Dermatol. Online J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular Senescence and Tumor Suppressor Gene P16","volume":"130","author":"Rayess","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0046-8177(98)90221-0","article-title":"Allelic Deletion at Chromosome 9p21(P16) and 17p13(P53) in Microdissected Sporadic Dysplastic Nevus","volume":"29","author":"Park","year":"1998","journal-title":"Hum. Pathol."},{"key":"ref_23","first-page":"675","article-title":"Alteration of Chromosome 9p21 and\/or P16 in Benign and Dysplastic Nevi Suggests a Role in Early Melanoma Progression (United States)","volume":"13","author":"Tran","year":"2002","journal-title":"Cancer Causes Control"},{"key":"ref_24","first-page":"243","article-title":"Molecular Alterations at Chromosome 9p21 in Melanocytic Naevi and Melanoma","volume":"158","author":"Sini","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ccell.2018.05.014","article-title":"Bi-Allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation","volume":"34","author":"Zeng","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jid.2020.03.938","article-title":"Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM Syndrome","volume":"140","author":"Christodoulou","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13000-015-0431-9","article-title":"A P16-Ki-67-HMB45 Immunohistochemistry Scoring System as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma","volume":"10","author":"Uguen","year":"2015","journal-title":"Diagn. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.aad5214","article-title":"MTAP Deletion Confers Enhanced Dependency on the PRMT5 Arginine Methyltransferase in Cancer Cells","volume":"351","author":"Kryukov","year":"2016","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rossi, E., Schinzari, G., Zizzari, I.G., Maiorano, B.A., Pagliara, M.M., Sammarco, M.G., Fiorentino, V., Petrone, G., Cassano, A., and Rindi, G. (2019). Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?. Cancers, 11.","DOI":"10.3390\/cancers11081055"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/cup.13721","article-title":"P16 Range of Expression in Dermal Predominant Benign Epithelioid and Spindled Nevi and Melanoma","volume":"47","author":"Oaxaca","year":"2020","journal-title":"J. Cutan. Pathol."},{"key":"ref_31","first-page":"2713","article-title":"Loss of Expression of the P16\/Cyclin-Dependent Kinase Inhibitor 2 Tumor Suppressor Gene in Melanocytic Lesions Correlates with Invasive Stage of Tumor Progression","volume":"55","author":"Reed","year":"1995","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/jid.2011.197","article-title":"Selective Loss of Wild-Type P16INK4a Expression in Human Nevi","volume":"131","author":"Scurr","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/cup.14717","article-title":"Ancillary Immunohistochemistry Testing for Loss of P16 in Melanoma: A Systematic Review and Meta-analysis of Diagnostic Accuracy Studies","volume":"51","author":"Chinchanikar","year":"2024","journal-title":"J. Cutan. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pizzimenti, C., Fiorentino, V., Ieni, A., Rossi, E.D., German\u00e0, E., Giovanella, L., Lentini, M., Alessi, Y., Tuccari, G., and Campenn\u00ec, A. (2023). BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210024"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cup.14438","article-title":"Potential Diagnostic Utility of PRAME and P16 Immunohistochemistry in Melanocytic Nevi and Malignant Melanoma","volume":"50","author":"Bahmad","year":"2023","journal-title":"J. Cutan. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)63695-4","article-title":"Characterization of Methylthioadenosin Phosphorylase (MTAP) Expression in Malignant Melanoma","volume":"163","author":"Behrmann","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1375\/twin.14.5.422","article-title":"Polymorphisms in Nevus-Associated Genes MTAP, PLA2G6 and IRF4 and the Risk of Invasive Cutaneous Melanoma","volume":"14","author":"Kvaskoff","year":"2011","journal-title":"Twin Res. Hum. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archderm.142.4.471","article-title":"Tissue Microarray Analysis of Methylthioadenosine Phosphorylase Protein Expression in Melanocytic Skin Tumors","volume":"142","author":"Wild","year":"2006","journal-title":"Arch. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1111\/j.1600-0625.2010.01072.x","article-title":"Methylthioadenosine Phosphorylase Represents a Predictive Marker for Response to Adjuvant Interferon Therapy in Patients with Malignant Melanoma","volume":"19","author":"Meyer","year":"2010","journal-title":"Exp. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100495","DOI":"10.1016\/j.modpat.2024.100495","article-title":"Loss of MTAP Expression by Immunohistochemistry Is a Surrogate Marker for Homozygous 9p21.3 Deletion in Urothelial Carcinoma","volume":"37","author":"Vlajnic","year":"2024","journal-title":"Mod. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1038\/s41598-025-95785-2","article-title":"Improving Diagnostic Accuracy in Atypical Melanocytic Tumors Using P16 Immunohistochemistry and 9p21 Fluorescence in Situ Hybridization: Analysis of 206 Second Opinion Cases","volume":"15","author":"Vergara","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"155350","DOI":"10.1016\/j.prp.2024.155350","article-title":"Concordance between CDKN2A Homozygous Deletion and MTAP Immunohistochemical Loss in Fluoroedenite-Induced Pleural Mesothelioma: An Immunohistochemical and Molecular Study on a Single-Institution Series","volume":"259","author":"Broggi","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ozkizilkaya, H.I., Vinocha, A., Dono, A., Ogunbona, O.B., Toruner, G.A., Aung, P.P., Kamiya Matsuoka, C., Esquenazi, Y., DeMonte, F., and Ballester, L.Y. (2024). MTAP and P16 IHC as Markers for CDKN2A\/B Loss in Meningiomas. Cancers, 16.","DOI":"10.3390\/cancers16193299"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5858\/arpa.2021-0331-OA","article-title":"A Combination of MTAP and P16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas","volume":"147","author":"Brcic","year":"2023","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP Immunohistochemistry Is an Accurate and Reproducible Surrogate for CDKN2A Fluorescence in Situ Hybridization in Diagnosis of Malignant Pleural Mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/DAD.0000000000003139","article-title":"Methylthioadenosine Phosphorylase (MTAP) and P16 Expression in Melanocytic Nevi and Melanoma with Molecular Correlation","volume":"47","author":"He","year":"2025","journal-title":"Am. J. Dermatopathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.annonc.2024.08.2339","article-title":"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: Results from phase I dose exploration","volume":"35","author":"Rodon","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Garutti, M., Targato, G., Buriolla, S., Palmero, L., Minisini, A.M., and Puglisi, F. (2021). CDK4\/6 Inhibitors in Melanoma: A Comprehensive Review. Cells, 10.","DOI":"10.3390\/cells10061334"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/PAS.0000000000000160","article-title":"Comparative Analysis of Atypical Spitz Tumors With Heterozygous Versus Homozygous 9p21 Deletions for Clinical Outcomes, Histomorphology, BRAF Mutation, and P16 Expression","volume":"38","author":"Yazdan","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1054\/bjoc.2000.1513","article-title":"Definition of the Role of Chromosome 9p21 in Sporadic Melanoma through Genetic Analysis of Primary Tumours and Their Metastases","volume":"83","author":"Palmieri","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41379-022-01026-6","article-title":"Towards Diagnostic Criteria for Malignant Deep Penetrating Melanocytic Tumors Using Single Nucleotide Polymorphism Array and Next-Generation Sequencing","volume":"35","author":"Ebbelaar","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2010.07.031","article-title":"P16 Expression: A Marker of Differentiation between Childhood Malignant Melanomas and Spitz Nevi","volume":"65","author":"Agoumi","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2016.07.029","article-title":"Loss of P16 Expression and Copy Number Changes of CDKN2A in a Spectrum of Spitzoid Melanocytic Lesions","volume":"58","author":"Harms","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.euo.2021.10.006","article-title":"Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer","volume":"6","author":"Alhalabi","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Fiorentino, V., Pizzimenti, C., Franchina, M., Rossi, E.D., Tralongo, P., Carlino, A., Larocca, L.M., Martini, M., Fadda, G., and Pierconti, F. (2023). Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512489"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jclinpath-2020-206633","article-title":"Methylation study of the Paris system for reporting urinary (TPS) categories","volume":"74","author":"Pierconti","year":"2021","journal-title":"J. Clin. Pathol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/971\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:30:29Z","timestamp":1768908629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27020971"],"URL":"https:\/\/doi.org\/10.3390\/ijms27020971","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}